藥靶細(xì)胞
藥靶試劑耗材
診斷原料
診斷試劑盒
其他
科研細(xì)胞
藥靶模型
診斷試劑
技術(shù)服務(wù)
新聞中心
關(guān)于我們
聯(lián)系我們
藥靶模型
Drug Target Model
CBP74217
| I. Background | |
| Different innate immune pathways converge to Stimulator of interferon genes (STING) and trigger type I interferon responses after recognition of abnormal nucleic acids in the cells. This non-redundant function renders STING a major player in immunosurveillance, and an emerging target for cancer and infectious diseases therapeutics. Beyond somatic mutations that often occur in cancer, the human gene encoding STING protein, TMEM173 (STING1), holds great genetic heterogeneity; R232, HAQ (R71H-G230A-R293Q) and H232 are the most common alleles. | |
| II. Introduction | |
| Host Cell: | THP-1 |
| Expressed gene: | R232-hSTING-KI |
| Stability: | 32 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
| Freeze Medium: | 90% FBS+10% DMSO |
| Culture Medium: | RPMI-1640+10% Heat Inactivated-FBS+10 μg/ml Blasticidin+100 μg/ml Zeocin+100 μg/ml Normocin |
| Storage: | Liquid nitrogen |
| III. Description of Host Cell Line | |
| Organism: | Homo sapiens, human |
| Tissue: | peripheral blood |
| Disease: | acute monocytic leukemia |
| Morphology: | monocyte |
| Growth Properties: | suspension |
| IV. Representative Data | |
![]() Figure 1. Sanger of R232-STING-KI ISRE-Luc NFκB-SEAP THP-1. |
|
掃二維碼
